- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02017483
Explore the Association Between the Emotion Recognition and the Attention Processing Under the Emotional Stimuli in ADHD
Study Overview
Status
Conditions
Detailed Description
The sample will consist of 100 children and adolescent with ADHD and 100 typical controls, ages 8-16. The ADHD group inclusion criteria are patients who have clinically diagnosis of DSM-IV ADHD confirmed by the K-SADS-E, and have IQ > 80; and whose parents consent to this study.
The measurements will be included:
Diagnostic assessment tools:
- Chinese version of Kiddie-Schedule for Affective Disorders and Schizophrenia-Epidemiology version.
- Conners' Parent/Teacher Rating Scale- Revised: Short Form, CPRS-R:S/CTRS-R:S.
- Swanson, Nolan, and Pelham, Version Ⅳ(SNAP-Ⅳ)Rating Scale - Parent/ Teacher Form.
Emotion assessment tools:
- Facial emotion recognition task.
- Emotional attentional bias task.
- Emotional Go/ No Go task.
Cognitive assessment tool:
- Wechsler Intelligence Scale for Children-Fourth Edition Chinese Version.
This study could offer the suggestion for the further intervention of social function in ADHD.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Taipei, Taiwan
- Recruiting
- National Taiwan Univeristy Hospital
-
Contact:
- Susan Shur-Fen Gau, MD, PhD
- Phone Number: 66802 886-2-23123456
- Email: gaushufe@ntu.edu.tw
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
Control group
- The subjects without ADHD.
- Ages range from 8 to 16
- Full scale IQ ≥ 80
- The subjects who and whose parents consent to this study.
ADHD group
- Patients who have clinically diagnosis of DSM-IV ADHD confirmed by the K-SADS-E.
- Ages range from 8 to 16
- Full scale IQ ≥ 80
- Patients who and whose parents consent to this study.
Exclusion Criteria:
- Mental Retardation
- Schizophrenia, Schizoaffective Disorder
- Mood Disorders
- Organic Psychosis
- Learning Disorder
- Pervasive Developmental Disorder
- The subjects of control group if have a history of the following condition as defined by DSM-IV: ADHD in addition to the above exclusion criteria will be excluded.
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Control
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The error rate in facial emotion judgements on computerized task
Time Frame: up to 2 years
|
Investigator used the e-prime program to assess the error rate in facial emotion judgements.
Participants need to judge the emotion of the face stimuli presented on the laptop.
|
up to 2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The reaction time of attentional bias for pairs of face stimuli(happy/neutral or angry/neutral faces) on dot-prob task
Time Frame: up to 2 years
|
Investigator presented pairs of face stimuli with emotional and neutral expressions and probed the allocation of attention to these stimuli for presentation times of 150 and 500 ms to assess the reaction time of attentional bias.
Participants need to press the dot after the prob.
|
up to 2 years
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The attentional inhibition control(omission errors and commission errors) in emotional go/no go task
Time Frame: up to 2 years
|
Investigator used go/ no go task to assess participants' omission errors and commission errors, participants just need to press the keyboard and the number of errors were recorded.
|
up to 2 years
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Susan Shur-Fen Gau, MD, PhD, National Taiwan University Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 201211008RIB
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Attention Deficit/Hyperactivity Disorder
-
King's College LondonActive, not recruitingAttention-Deficit Hyperactivity Disorder | Attention-Deficit Hyperactivity Disorder SymptomsUnited Kingdom
-
Cingulate TherapeuticsSuspendedPhase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301ADHD | Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Ornit CohenUnknownAttention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | Attention Deficit Disorder | Attention Deficit Disorders With Hyperactivity | Attention Deficit Hyperactivity DisordersIsrael
-
Cingulate TherapeuticsPremier Research Group plcCompletedADHD | Attention Deficit Hyperactivity Disorder | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Central South UniversityRecruitingAttention-Deficit/Hyperactivity DisorderChina
-
Qbtech ABEnrolling by invitationAttention Deficit Disorder With Hyperactivity (ADHD) | Attention Deficit Disorder (ADD)United States
-
Universidade do Sul de Santa CatarinaAssociação Brasileira de Cannabis MedicinalRecruitingAttention-Deficit/Hyperactivity Disorder (ADHD)Brazil
-
Nanjing Medical UniversityRecruitingAdult Attention Deficit Hyperactivity DisorderChina
-
Children's Hospital Medical Center, CincinnatiPatient-Centered Outcomes Research Institute; Children's Hospital of Philadelphia and other collaboratorsNot yet recruitingAttention-Deficit/Hyperactivity Disorder (ADHD)United States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAttention Deficit Disorder With HyperactivityUnited States